Flexeril and Sular drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Sular (nisoldipine). Common drug interactions include insomnia among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Sular. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Sular?

Sular has active ingredients of nisoldipine. It is often used in high blood pressure. eHealthMe is studying from 1,757 Sular users. Check the latest studies of Sular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

22 people who take Flexeril and Sular together, and have interactions are studied.

Flexeril and Sular drug interactions.

What are the common drug interactions of Flexeril and Sular, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Irritable bowel syndrome
  3. Kidney infection
  4. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  5. Myalgia (muscle pain)
  6. Nail disorder (disease of nail)
  7. Nervousness
  8. Obesity (having too much body fat)
  9. Osteoporosis (bones weak and more likely to break)
  10. Pain

male:

  1. Abdominal pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Myalgia (muscle pain)
  4. Pain in extremity
  5. Pallor
  6. Vomiting
  7. Aspartate aminotransferase increased
  8. Blood glucose increased
  9. Colitis (inflammation of colon)
  10. Drug hypersensitivity

What are the common drug interactions of Flexeril and Sular, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Asthenia (weakness)
  4. Cardiac failure congestive
  5. Device dislocation
  6. Dystonia (abnormal muscle tone)
  7. Emotional disorder
  8. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Nausea (feeling of having an urge to vomit)

30-39:

  1. Blood pressure fluctuation
  2. Diarrhoea
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Flushing (the warm, red condition of human skin)
  6. Headache (pain in head)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Loss of consciousness
  9. Pallor
  10. Thrombocytopenia (decrease of platelets in blood)

40-49:

n/a

50-59:

  1. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  2. Asthma
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Depression
  6. Drug ineffective
  7. Dyspnoea (difficult or laboured respiration)
  8. Ear pain
  9. Flushing (the warm, red condition of human skin)
  10. Headache (pain in head)

60+:

  1. Abdominal pain
  2. Myalgia (muscle pain)
  3. Acute stress disorder
  4. Blood alkaline phosphatase increased
  5. Cardiac failure congestive
  6. Chest pain
  7. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 18.18%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.09%
  3. Pain: 2 people, 9.09%
  4. Headache (pain in head): 2 people, 9.09%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Sular?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Sular:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sular:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sular and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and nisoldipine (the active ingredients of Flexeril and Sular, respectively), and Flexeril and Sular (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: